<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>
<head>
<title>extropians: AGING/CANCER: Telomerase regulatory gene found</title>
<meta name="Author" content="Robert J. Bradbury (bradbury@aeiveos.com)">
<meta name="Subject" content="AGING/CANCER: Telomerase regulatory gene found">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<h1>AGING/CANCER: Telomerase regulatory gene found</h1>
<!-- received="Tue Sep 25 10:24:53 2001" -->
<!-- isoreceived="20010925162453" -->
<!-- sent="Tue, 25 Sep 2001 07:24:41 -0700 (PDT)" -->
<!-- isosent="20010925142441" -->
<!-- name="Robert J. Bradbury" -->
<!-- email="bradbury@aeiveos.com" -->
<!-- subject="AGING/CANCER: Telomerase regulatory gene found" -->
<!-- id="Pine.LNX.4.10.10109250700390.2900-100000@server.aeiveos.com" -->
<strong>From:</strong> Robert J. Bradbury (<a href="mailto:bradbury@aeiveos.com?Subject=Re:%20AGING/CANCER:%20Telomerase%20regulatory%20gene%20found&In-Reply-To=&lt;Pine.LNX.4.10.10109250700390.2900-100000@server.aeiveos.com&gt;"><em>bradbury@aeiveos.com</em></a>)<br>
<strong>Date:</strong> Tue Sep 25 2001 - 08:24:41 MDT
<p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="7498.html">Anders Sandberg: "Re: Fw: [_] Power of Press -"</a>
<li><strong>Previous message:</strong> <a href="7496.html">hal@finney.org: "Re: Fw: [_] Power of Press -"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#7497">[ date ]</a>
<a href="index.html#7497">[ thread ]</a>
<a href="subject.html#7497">[ subject ]</a>
<a href="author.html#7497">[ author ]</a>
</ul>
<hr noshade><p>
<!-- body="start" -->
<p>
<em>&gt;From PubMed
</em><br>
<p>Cancer Res 2001 Feb 15;61(4):1250-4
<br>
Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P.
<br>
The ZNF217 gene amplified in breast cancers promotes immortalization of
<br>
human mammary epithelial cells.  
<br>
<a href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11245413&dopt=Abstract">http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11245413&dopt=Abstract</a>
<br>
<p><em>&gt; Abstract:
</em><br>
<em>&gt; 
</em><br>
<em>&gt; The functional consequences of overexpression of a candidate oncogene on
</em><br>
<em>&gt; chromosome 20q13.2, ZNF217, were examined by transducing the gene into
</em><br>
<em>&gt; finite life span human mammary epithelial cells (HMECs). In four independent
</em><br>
<em>&gt; experiments, ZNF217-transduced cultures gave rise to immortalized cells.
</em><br>
<em>&gt; HMECs that overcame senescence initially exhibited heterogeneous growth
</em><br>
<em>&gt; and continued telomere erosion, followed by increasing telomerase
</em><br>
<em>&gt; activity, stabilization of telomere length, and resistance to transforming
</em><br>
<em>&gt; growth factor beta growth inhibition. The incremental changes in telomerase
</em><br>
<em>&gt; activity and growth that occurred in ZNF217-transduced cultures after
</em><br>
<em>&gt; they overcame senescence were similar to the conversion pattern we have
</em><br>
<em>&gt; described previously in rare HMEC lines immortalized after exposure to
</em><br>
<em>&gt; a chemical carcinogen. Aberrant expression of ZNF217 may be selected for
</em><br>
<em>&gt; during breast cancer progression because it allows breast cells to overcome
</em><br>
<em>&gt; senescence and attain immortality.
</em><br>
<em>&gt; 
</em><br>
<p>This puts a pretty hard stamp of approval on human telemere length and
<br>
the limits on which cell types that express telomerase as being parts of a
<br>
genomic anti-cancer program.  It also provides a possible drug target.
<br>
I expect ZNF217 is a Zinc Finger DNA binding protein that activates
<br>
telomerase meaning that one could target its degradation with ribozymes
<br>
or blocking it with antisense-RNA.  Alternatively one could develop the
<br>
means to flood rapidly dividing cells with a specific decoy DNA sequence
<br>
to which it binds thereby avoiding its effects in activating the telomerase
<br>
gene.
<br>
<p><em>&gt;From an anti-aging standpoint, turning this gene on in the stem cells
</em><br>
remaining in an adult body could be quite useful.
<br>
<p>Related:
<br>
Genes Dev 2001 Jan 1;15(1):50-65
<br>
Elenbaas B, et al
<br>
Human breast cancer cells generated by oncogenic transformation of primary
<br>
mammary epithelial cells.
<br>
<a href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11156605&dopt=Abstract">http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11156605&dopt=Abstract</a>
<br>
<p>Int J Oncol. 1998 Mar;12(3):499-507. Review.
<br>
Band V.
<br>
The role of retinoblastoma and p53 tumor suppressor pathways in human
<br>
mammary epithelial cell immortalization.
<br>
<a href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9472085&dopt=Abstract">http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9472085&dopt=Abstract</a>
<br>
<p><!-- body="end" -->
<hr noshade>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="7498.html">Anders Sandberg: "Re: Fw: [_] Power of Press -"</a>
<li><strong>Previous message:</strong> <a href="7496.html">hal@finney.org: "Re: Fw: [_] Power of Press -"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#7497">[ date ]</a>
<a href="index.html#7497">[ thread ]</a>
<a href="subject.html#7497">[ subject ]</a>
<a href="author.html#7497">[ author ]</a>
</ul>
<!-- trailer="footer" -->
<hr noshade>
<p>
<small>
<em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2b30</a> 
: <em>Fri Oct 12 2001 - 14:40:57 MDT</em>
</em>
</small>
</body>
</html>
